Drug master file right of reference, the contract controls

A letter of authorization is three paragraphs long and underpins a marketing application. The obligations that keep it meaningful sit in the supply agreement.

What is a drug master file right of reference?

A right of reference is permission from a drug master file holder, normally an active ingredient or excipient supplier, for a regulator to review the confidential technical content of that file in support of someone else's application. It is granted through a letter of authorization naming the applicant, the file and the specific material. The applicant never sees the content. That dependency makes the supply agreement the only place where the applicant can secure the obligations, notification duties and continuity protections the reference actually relies on.

Last updated: October 2, 2026 · Reviewed by the Aavenir Life Sciences & Pharma practice

Key takeaways

  • ✓A letter of authorization is a permission, not a performance obligation, so the duties behind it must sit in the supply agreement.
  • ✓Applicants cannot see master file content, which makes supplier change notification the only visibility into what their filing relies on.
  • ✓A withdrawn or unsupported file can stall an application, so continuity and successor terms need to be contractual.
  • ✓Deficiency response support is a timed obligation, and without a contractual turnaround the applicant carries the delay.

Most marketing applications rest partly on technical information the applicant has never read. The manufacturing detail for an active ingredient sits in the supplier's master file, and the applicant references it with the supplier's permission. That permission arrives as a letter of authorization: short, standard and consequential. It tells the regulator it may review the file in support of a named application.

What the letter does not do is commit the supplier to anything beyond granting access. It does not promise the file is current. It does not require notice before a manufacturing change. It does not oblige the supplier to respond when the regulator raises a deficiency against the referenced content, and it does not address what happens if the supplier is acquired or stops supporting the file. Every one of those is a live risk to the applicant's filing.

Those obligations have to come from the supply or quality agreement. The letter of authorization is the visible artefact; the contract is where the dependency is actually managed. Treating the two as one document is how applicants discover, during a review cycle, that they have permission without protection.

Five dependencies the letter does not cover

The reference creates a structural asymmetry: the applicant carries regulatory accountability for content it cannot inspect. Each dependency below needs a contractual counterpart, and each is a common finding when a filing runs into trouble.

  • Change notification, a supplier can alter a process, site or specification and update the file without telling the applicant, whose own filing may require a variation.
  • File currency, the applicant cannot verify that the file is complete, current or free of outstanding regulatory correspondence, and a deficient file becomes the applicant's review problem.
  • Deficiency response, when a regulator queries the referenced content, only the holder can answer, and an unhurried response delays the applicant's approval.
  • Withdrawal and support, a holder who withdraws the file or stops maintaining it leaves the applicant to requalify an alternative source under time pressure.
  • Successor and assignment, an acquisition can change who holds the file, and without successor obligations the new holder inherits no commitment to the applicant.

These are not hypothetical. Each has a straightforward contractual answer, and in practice the answer is often missing because the supply agreement was negotiated on price, volume and delivery terms while the regulatory dependency was treated as settled by the letter of authorization alone.

The applicant is accountable for content it cannot see

Regulators hold the applicant responsible for the quality of its application, including the portions supported by reference to another party's master file. The applicant cannot audit that content directly. The practical consequence is that contractual notification, support and continuity obligations are not commercial niceties, they are the applicant's only instrument for managing a dependency it is answerable for.

What to hold on the contract record

Five tracked elements make the dependency visible and manageable. Each should sit on the supplier contract record with an owner and a review cadence, not in a regulatory affairs folder.

  • Letter of authorization register. the current letter for each referenced file, the material and application it covers, its date, and a link to the agreement that obliges the supplier to maintain it.
  • Change notification terms. the notice period for process, site, specification and supplier changes, with the categories defined so that a change requiring a variation cannot be classified as minor unilaterally.
  • Support and response commitment. an obligation to support deficiency responses within a defined period, tracked as a dated duty when a query is raised rather than negotiated at the point of urgency.
  • Continuity and withdrawal notice. a minimum notice period before the holder ceases to maintain or support the file, long enough to qualify an alternative source.
  • Successor obligations. an express requirement that assignment or transfer of the file carries the applicant's rights and the supplier's duties to the successor holder.

A five-step roadmap to close the exposure

Step 1, Inventory every reference

Establish which applications depend on which master files, held by which suppliers, for which materials. The list is usually incomplete because references accumulate across products and years. Build it from the applications rather than from supplier records, since a supplier may hold several files and only some are referenced.

Step 2, Match each reference to its agreement

For every reference, identify the supply or quality agreement with the holder and check whether it contains notification, support, continuity and successor terms. Record the result. References with no supporting agreement, or with an agreement silent on these points, are the priority exposures.

Step 3, Define change categories contractually

Vague notification terms fail in practice because the supplier classifies its own changes. Specify the change categories that trigger notice, the notice period for each, and the applicant's right to assess regulatory impact before implementation. Tie the definitions to the quality agreement where one exists, since these are the same quality agreement obligations pharma teams keep missing.

Step 4, Make support obligations dated

Convert the deficiency support commitment into a tracked obligation: when a regulatory query touches referenced content, the supplier's response window starts and is monitored. Without a start-stop mechanism the commitment is an intention, and the applicant absorbs the schedule risk.

Step 5, Review letters and terms on a cycle

Letters of authorization go stale, applications change scope, and suppliers reorganize. Review the register periodically against current applications, confirm each letter is still valid for its stated scope, and refresh terms at renewal rather than at the point a problem appears, applying the same evidence discipline as a 21 CFR Part 11 and GxP audit checklist.

Hold the reference dependency on the contract

Aavenir tracks letters of authorization, change notification windows and support commitments as monitored obligations on the supplier agreement.

Book a demo

Where this surfaces in practice

Two moments expose the gap. The first is a review cycle, when a regulator raises a deficiency against referenced content and the applicant discovers it has no contractual lever to compel a timely response. The second is a supplier change, when a site transfer or process modification reaches the applicant after implementation and triggers an unplanned variation. Both are predictable, both are addressable in drafting, and both are substantially cheaper to handle at negotiation than in a review clock. The organizations that handle them well are generally the ones that treat the letter of authorization as an index entry pointing at a contract, rather than as the control itself.

Dependency, contractual answer and evidence

The table sets out each dependency, the term that addresses it, and the record that demonstrates the control is operating.

DependencyContractual termTracked asEvidence retained
Undisclosed supplier changeChange notification with categoriesNotice window per change typeNotification record, impact assessment
Stale or deficient fileFile maintenance obligationPeriodic confirmationSupplier confirmation, letter date
Slow deficiency responseSupport commitment with periodDated obligation on queryQuery date, response date
File withdrawalMinimum continuity noticeNotice period monitoredWithdrawal notice, requalification plan
Holder changes handsSuccessor and assignment termsReviewed at any transferSuccessor acknowledgement

A right of reference is an efficient arrangement that lets suppliers protect proprietary process detail while applicants build filings on it. The inefficiency is in how the dependency gets managed. A letter of authorization grants access and nothing more, yet it is routinely treated as if it settled the relationship. The obligations that keep a filing supportable, notice before change, support during review, continuity of the file and the survival of both through a transfer, are supply agreement terms. Registering each reference, matching it to its agreement, and tracking the notification and support windows as live obligations converts an invisible dependency into one the applicant can actually manage.

For related guidance, see The quality leader’s guide to CDMO quality agreements, The sponsor’s guide to CRO master service agreements and Quality agreement tracking for sponsors and CDMOs.

FAQ

Right of reference questions

What does a letter of authorization actually grant? +
It grants a regulator permission to review the confidential content of a master file in support of a specific, named application. It identifies the holder, the file, the authorized party and the material concerned. It does not give the applicant access to the content, and it does not by itself create any ongoing obligation on the holder to maintain the file or support the application.
Can an applicant see the master file content it references? +
No. The point of the master file mechanism is that the holder can submit proprietary manufacturing and quality detail to a regulator without disclosing it to customers. The applicant relies on the reference without visibility, which is precisely why contractual notification and support obligations carry so much weight in this arrangement.
What happens if the supplier changes its process without telling us? +
The referenced content changes while the applicant's filing assumptions do not. Depending on the change, a variation or supplement may be required, and the applicant may only learn of it when a regulator raises a question or during a routine review. A contractual change notification term with defined categories and notice periods is the only reliable protection.
Who responds to a regulatory deficiency on referenced content? +
Only the file holder can, because the applicant does not have the underlying data. This makes the response timeline a dependency the applicant cannot control unless the agreement sets a defined support commitment. Tracking the query date and the contractual response window as a dated obligation is what gives the applicant a basis to escalate.
What if the master file holder is acquired? +
Without express successor terms, the acquiring party inherits the file but not necessarily any commitments to the applicant. Supply and quality agreements should require that rights of reference and the holder's notification, support and continuity duties pass to any successor, and the position should be reviewed whenever a transfer occurs.
How often should letters of authorization be reviewed? +
On a defined cycle and at any change in application scope, supplier ownership or material source. Letters are written for specific applications and materials, so a product change can leave a letter technically out of scope. A periodic review against current applications catches that before a review cycle does.

Turn a letter of authorization into a managed dependency

Register every right of reference against its supply agreement, and track change notification, support and continuity commitments as monitored obligations.

  • ✓Letter of authorization register linked to the governing supplier agreement
  • ✓Change notification and deficiency support windows tracked with owners
  • ✓Standalone or native on ServiceNow